Morpholine Amides: Classical but Underexplored Acylating Intermediates in Organic Synthesis
Synthesis · 01.12.2025 · 57 (24) · 3639-3648
DOI: 10.1055/a-2675-3988 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synthesis, erschienen am 01.12.2025. Verfasst von Yohei Ogiwara. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Science and Technology Agency (JST PRESTO.
Abstract (Originalsprache)
Morpholine amides are classical yet underexplored acylating agents in organic synthesis. Compared to other amides, such as Weinreb amides, morpholine amides offer distinct advantages such as high water solubility, economic accessibility, and operational stability. This review highlights recent advancements in the use of morpholine amides for the synthesis of ketones, aldehydes, and acylsilanes via selective mono-addition of organometallic or hydride reagents. Their applications in key steps of complex molecule synthesis, including natural product synthesis, Vilsmeier–Haack reactions, and polymer recycling processes, are also discussed. Particular attention is paid to the unique reactivity and chemoselectivity of morpholine amides that distinguish them from other amide derivatives, offering practical and scalable strategies in modern synthetic chemistry.
Förderung
- Japan Science and Technology Agency (JST PRESTO
Zitieren
APA
Ogiwara, Y. (2025). Morpholine Amides: Classical but Underexplored Acylating Intermediates in Organic Synthesis. Synthesis, 57(24), 3639-3648. https://doi.org/10.1055/a-2675-3988
Vancouver
Ogiwara Y. Morpholine Amides: Classical but Underexplored Acylating Intermediates in Organic Synthesis. Synthesis. 2025;57(24):3639-3648. doi:10.1055/a-2675-3988
BibTeX
@article{Ogiwara2025,
author = {Ogiwara, Yohei},
title = {Morpholine Amides: Classical but Underexplored Acylating Intermediates in Organic Synthesis},
journal = {Synthesis},
year = {2025},
volume = {57},
number = {24},
pages = {3639--3648},
doi = {10.1055/a-2675-3988}
}
EUVIMED